Show
Sort by
-
- Journal Article
- A1
- open access
Different local, innate and adaptive immune responses are induced by two commercial Mycoplasma hyopneumoniae bacterins and an adjuvant alone
-
- Journal Article
- A1
- open access
CCR2-and Flt3-dependent inflammatory conventional type 2 dendritic cells are necessary for the induction of adaptive immunity by the human vaccine adjuvant system AS01
-
- Journal Article
- A1
- open access
Efficacy of three innovative bacterin vaccines against experimental infection with Mycoplasma hyopneumoniae
-
- Journal Article
- A1
- open access
Toll-like receptor agonists as adjuvants for inactivated porcine reproductive and respiratory syndrome virus (PRRSV) vaccine
-
- Journal Article
- A1
- open access
Vaccine strategies to improve anti-cancer cellular immune responses
-
- Journal Article
- A1
- open access
Systems immunology characterization of novel vaccine formulations for Mycoplasma hyopneumoniae bacterins
-
Use of concomitant androgen deprivation therapy in patients treated with early salvage radiotherapy for biochemical recurrence after radical prostatectomy : long-term results from a large, multi-institutional series
-
Impact of early salvage radiation therapy in patients with persistently elevated or rising prostate-specific antigen after radical prostatectomy
-
- Journal Article
- A1
- open access
A respiratory syncytial virus vaccine based on the small hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults : a first-in-humans study
-
Post-PEGylated and crosslinked polymeric ssRNA nanocomplexes as adjuvants targeting lymph nodes with increased cytolytic T cell inducing properties